Global Viral Vector Development Service Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Market Overview
The global Viral Vector Development Service market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Viral Vector Development Service market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Viral Vector Development Service market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Viral Vector Development Service market has been segmented into:
Retroviral Vectors
Lentiviral Vectors
Adenoviral Vectors
Adeno-associated Viral Vectors
Others Viral Vectors
By Application, Viral Vector Development Service has been segmented into:
Pharmaceutical Manufacturers
Biotechnology Companies
Research Institutes
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Viral Vector Development Service market presented in the report. This section sheds light on the sales growth of different regional and country-level Viral Vector Development Service markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Viral Vector Development Service market.
The report offers in-depth assessment of the growth and other aspects of the Viral Vector Development Service market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Viral Vector Development Service Market Share Analysis
Viral Vector Development Service competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Viral Vector Development Service sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Viral Vector Development Service sales, revenue and market share for each player covered in this report.
The major players covered in Viral Vector Development Service are:
UJIFILM Diosynth Biotechnologies
Cell and Gene Therapy Catapult
UniQure
Sanofi
Brammer Bio
Spark Therapeutics
FinVector
MassBiologics
Cobra Biologics
Table of Contents
1 Viral Vector Development Service Market Overview
1.1 Product Overview and Scope of Viral Vector Development Service
1.2 Classification of Viral Vector Development Service by Type
1.2.1 Global Viral Vector Development Service Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Viral Vector Development Service Revenue Market Share by Type in 2019
1.2.3 Retroviral Vectors
1.2.4 Lentiviral Vectors
1.2.5 Adenoviral Vectors
1.2.6 Adeno-associated Viral Vectors
1.2.7 Others Viral Vectors
1.3 Global Viral Vector Development Service Market by Application
1.3.1 Overview: Global Viral Vector Development Service Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical Manufacturers
1.3.3 Biotechnology Companies
1.3.4 Research Institutes
1.4 Global Viral Vector Development Service Market by Regions
1.4.1 Global Viral Vector Development Service Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Viral Vector Development Service (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Viral Vector Development Service Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Viral Vector Development Service Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Viral Vector Development Service Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Viral Vector Development Service Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Viral Vector Development Service Status and Prospect (2015-2025)
2 Company Profiles
2.1 UJIFILM Diosynth Biotechnologies
2.1.1 UJIFILM Diosynth Biotechnologies Details
2.1.2 UJIFILM Diosynth Biotechnologies Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 UJIFILM Diosynth Biotechnologies SWOT Analysis
2.1.4 UJIFILM Diosynth Biotechnologies Product and Services
2.1.5 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cell and Gene Therapy Catapult
2.2.1 Cell and Gene Therapy Catapult Details
2.2.2 Cell and Gene Therapy Catapult Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cell and Gene Therapy Catapult SWOT Analysis
2.2.4 Cell and Gene Therapy Catapult Product and Services
2.2.5 Cell and Gene Therapy Catapult Viral Vector Development Service Revenue, Gross Margin and Market Share (2018-2019)
2.3 UniQure
2.3.1 UniQure Details
2.3.2 UniQure Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 UniQure SWOT Analysis
2.3.4 UniQure Product and Services
2.3.5 UniQure Viral Vector Development Service Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi SWOT Analysis
2.4.4 Sanofi Product and Services
2.4.5 Sanofi Viral Vector Development Service Revenue, Gross Margin and Market Share (2018-2019)
2.5 Brammer Bio
2.5.1 Brammer Bio Details
2.5.2 Brammer Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Brammer Bio SWOT Analysis
2.5.4 Brammer Bio Product and Services
2.5.5 Brammer Bio Viral Vector Development Service Revenue, Gross Margin and Market Share (2018-2019)
2.6 Spark Therapeutics
2.6.1 Spark Therapeutics Details
2.6.2 Spark Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Spark Therapeutics SWOT Analysis
2.6.4 Spark Therapeutics Product and Services
2.6.5 Spark Therapeutics Viral Vector Development Service Revenue, Gross Margin and Market Share (2018-2019)
2.7 FinVector
2.7.1 FinVector Details
2.7.2 FinVector Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 FinVector SWOT Analysis
2.7.4 FinVector Product and Services
2.7.5 FinVector Viral Vector Development Service Revenue, Gross Margin and Market Share (2018-2019)
2.8 MassBiologics
2.8.1 MassBiologics Details
2.8.2 MassBiologics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 MassBiologics SWOT Analysis
2.8.4 MassBiologics Product and Services
2.8.5 MassBiologics Viral Vector Development Service Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cobra Biologics
2.9.1 Cobra Biologics Details
2.9.2 Cobra Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Cobra Biologics SWOT Analysis
2.9.4 Cobra Biologics Product and Services
2.9.5 Cobra Biologics Viral Vector Development Service Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Viral Vector Development Service Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Viral Vector Development Service Players Market Share
3.2.2 Top 10 Viral Vector Development Service Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Viral Vector Development Service Revenue and Market Share by Regions
4.2 North America Viral Vector Development Service Revenue and Growth Rate (2015-2020)
4.3 Europe Viral Vector Development Service Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Viral Vector Development Service Revenue and Growth Rate (2015-2020)
4.5 South America Viral Vector Development Service Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Viral Vector Development Service Revenue and Growth Rate (2015-2020)
5 North America Viral Vector Development Service Revenue by Countries
5.1 North America Viral Vector Development Service Revenue by Countries (2015-2020)
5.2 USA Viral Vector Development Service Revenue and Growth Rate (2015-2020)
5.3 Canada Viral Vector Development Service Revenue and Growth Rate (2015-2020)
5.4 Mexico Viral Vector Development Service Revenue and Growth Rate (2015-2020)
6 Europe Viral Vector Development Service Revenue by Countries
6.1 Europe Viral Vector Development Service Revenue by Countries (2015-2020)
6.2 Germany Viral Vector Development Service Revenue and Growth Rate (2015-2020)
6.3 UK Viral Vector Development Service Revenue and Growth Rate (2015-2020)
6.4 France Viral Vector Development Service Revenue and Growth Rate (2015-2020)
6.5 Russia Viral Vector Development Service Revenue and Growth Rate (2015-2020)
6.6 Italy Viral Vector Development Service Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Viral Vector Development Service Revenue by Countries
7.1 Asia-Pacific Viral Vector Development Service Revenue by Countries (2015-2020)
7.2 China Viral Vector Development Service Revenue and Growth Rate (2015-2020)
7.3 Japan Viral Vector Development Service Revenue and Growth Rate (2015-2020)
7.4 Korea Viral Vector Development Service Revenue and Growth Rate (2015-2020)
7.5 India Viral Vector Development Service Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Viral Vector Development Service Revenue and Growth Rate (2015-2020)
8 South America Viral Vector Development Service Revenue by Countries
8.1 South America Viral Vector Development Service Revenue by Countries (2015-2020)
8.2 Brazil Viral Vector Development Service Revenue and Growth Rate (2015-2020)
8.3 Argentina Viral Vector Development Service Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Viral Vector Development Service by Countries
9.1 Middle East & Africa Viral Vector Development Service Revenue by Countries (2015-2020)
9.2 Saudi Arabia Viral Vector Development Service Revenue and Growth Rate (2015-2020)
9.3 UAE Viral Vector Development Service Revenue and Growth Rate (2015-2020)
9.4 Egypt Viral Vector Development Service Revenue and Growth Rate (2015-2020)
9.5 South Africa Viral Vector Development Service Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Viral Vector Development Service Revenue and Market Share by Type (2015-2020)
10.2 Global Viral Vector Development Service Market Forecast by Type (2019-2024)
10.3 Retroviral Vectors Revenue Growth Rate (2015-2025)
10.4 Lentiviral Vectors Revenue Growth Rate (2015-2025)
10.5 Adenoviral Vectors Revenue Growth Rate (2015-2025)
10.6 Adeno-associated Viral Vectors Revenue Growth Rate (2015-2025)
10.7 Others Viral Vectors Revenue Growth Rate (2015-2025)
11 Global Viral Vector Development Service Market Segment by Application
11.1 Global Viral Vector Development Service Revenue Market Share by Application (2015-2020)
11.2 Viral Vector Development Service Market Forecast by Application (2019-2024)
11.3 Pharmaceutical Manufacturers Revenue Growth (2015-2020)
11.4 Biotechnology Companies Revenue Growth (2015-2020)
11.5 Research Institutes Revenue Growth (2015-2020)
12 Global Viral Vector Development Service Market Size Forecast (2021-2025)
12.1 Global Viral Vector Development Service Market Size Forecast (2021-2025)
12.2 Global Viral Vector Development Service Market Forecast by Regions (2021-2025)
12.3 North America Viral Vector Development Service Revenue Market Forecast (2021-2025)
12.4 Europe Viral Vector Development Service Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Viral Vector Development Service Revenue Market Forecast (2021-2025)
12.6 South America Viral Vector Development Service Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Viral Vector Development Service Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Viral Vector Development Service Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Viral Vector Development Service by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Viral Vector Development Service Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Viral Vector Development Service Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. UJIFILM Diosynth Biotechnologies Corporate Information, Location and Competitors
Table 6. UJIFILM Diosynth Biotechnologies Viral Vector Development Service Major Business
Table 7. UJIFILM Diosynth Biotechnologies Viral Vector Development Service Total Revenue (USD Million) (2017-2018)
Table 8. UJIFILM Diosynth Biotechnologies SWOT Analysis
Table 9. UJIFILM Diosynth Biotechnologies Viral Vector Development Service Product and Solutions
Table 10. UJIFILM Diosynth Biotechnologies Viral Vector Development Service Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Cell and Gene Therapy Catapult Corporate Information, Location and Competitors
Table 12. Cell and Gene Therapy Catapult Viral Vector Development Service Major Business
Table 13. Cell and Gene Therapy Catapult Viral Vector Development Service Total Revenue (USD Million) (2018-2019)
Table 14. Cell and Gene Therapy Catapult SWOT Analysis
Table 15. Cell and Gene Therapy Catapult Viral Vector Development Service Product and Solutions
Table 16. Cell and Gene Therapy Catapult Viral Vector Development Service Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. UniQure Corporate Information, Location and Competitors
Table 18. UniQure Viral Vector Development Service Major Business
Table 19. UniQure Viral Vector Development Service Total Revenue (USD Million) (2017-2018)
Table 20. UniQure SWOT Analysis
Table 21. UniQure Viral Vector Development Service Product and Solutions
Table 22. UniQure Viral Vector Development Service Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Sanofi Corporate Information, Location and Competitors
Table 24. Sanofi Viral Vector Development Service Major Business
Table 25. Sanofi Viral Vector Development Service Total Revenue (USD Million) (2017-2018)
Table 26. Sanofi SWOT Analysis
Table 27. Sanofi Viral Vector Development Service Product and Solutions
Table 28. Sanofi Viral Vector Development Service Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Brammer Bio Corporate Information, Location and Competitors
Table 30. Brammer Bio Viral Vector Development Service Major Business
Table 31. Brammer Bio Viral Vector Development Service Total Revenue (USD Million) (2017-2018)
Table 32. Brammer Bio SWOT Analysis
Table 33. Brammer Bio Viral Vector Development Service Product and Solutions
Table 34. Brammer Bio Viral Vector Development Service Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Spark Therapeutics Corporate Information, Location and Competitors
Table 36. Spark Therapeutics Viral Vector Development Service Major Business
Table 37. Spark Therapeutics Viral Vector Development Service Total Revenue (USD Million) (2017-2018)
Table 38. Spark Therapeutics SWOT Analysis
Table 39. Spark Therapeutics Viral Vector Development Service Product and Solutions
Table 40. Spark Therapeutics Viral Vector Development Service Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. FinVector Corporate Information, Location and Competitors
Table 42. FinVector Viral Vector Development Service Major Business
Table 43. FinVector Viral Vector Development Service Total Revenue (USD Million) (2017-2018)
Table 44. FinVector SWOT Analysis
Table 45. FinVector Viral Vector Development Service Product and Solutions
Table 46. FinVector Viral Vector Development Service Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. MassBiologics Corporate Information, Location and Competitors
Table 48. MassBiologics Viral Vector Development Service Major Business
Table 49. MassBiologics Viral Vector Development Service Total Revenue (USD Million) (2017-2018)
Table 50. MassBiologics SWOT Analysis
Table 51. MassBiologics Viral Vector Development Service Product and Solutions
Table 52. MassBiologics Viral Vector Development Service Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Cobra Biologics Corporate Information, Location and Competitors
Table 54. Cobra Biologics Viral Vector Development Service Major Business
Table 55. Cobra Biologics Viral Vector Development Service Total Revenue (USD Million) (2017-2018)
Table 56. Cobra Biologics SWOT Analysis
Table 57. Cobra Biologics Viral Vector Development Service Product and Solutions
Table 58. Cobra Biologics Viral Vector Development Service Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Viral Vector Development Service Revenue (Million USD) by Players (2015-2020)
Table 60. Global Viral Vector Development Service Revenue Share by Players (2015-2020)
Table 61. Global Viral Vector Development Service Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Viral Vector Development Service Revenue Market Share by Regions (2015-2020)
Table 63. North America Viral Vector Development Service Revenue by Countries (2015-2020)
Table 64. North America Viral Vector Development Service Revenue Market Share by Countries (2015-2020)
Table 65. Europe Viral Vector Development Service Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Viral Vector Development Service Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Viral Vector Development Service Revenue by Countries (2015-2020)
Table 68. South America Viral Vector Development Service Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Viral Vector Development Service Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Viral Vector Development Service Revenue Market Share by Countries (2015-2020)
Table 71. Global Viral Vector Development Service Revenue (Million USD) by Type (2015-2020)
Table 72. Global Viral Vector Development Service Revenue Share by Type (2015-2020)
Table 73. Global Viral Vector Development Service Revenue Forecast by Type (2021-2025)
Table 74. Global Viral Vector Development Service Revenue by Application (2015-2020)
Table 75. Global Viral Vector Development Service Revenue Share by Application (2015-2020)
Table 76. Global Viral Vector Development Service Revenue Forecast by Application (2021-2025)
Table 77. Global Viral Vector Development Service Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Viral Vector Development Service Picture
Figure 2. Global Viral Vector Development Service Revenue Market Share by Type in 2019
Figure 3. Retroviral Vectors Picture
Figure 4. Lentiviral Vectors Picture
Figure 5. Adenoviral Vectors Picture
Figure 6. Adeno-associated Viral Vectors Picture
Figure 7. Others Viral Vectors Picture
Figure 8. Viral Vector Development Service Revenue Market Share by Application in 2019
Figure 9. Pharmaceutical Manufacturers Picture
Figure 10. Biotechnology Companies Picture
Figure 11. Research Institutes Picture
Figure 12. Global Viral Vector Development Service Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Viral Vector Development Service Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Viral Vector Development Service Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Viral Vector Development Service Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Viral Vector Development Service Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Viral Vector Development Service Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Viral Vector Development Service Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Viral Vector Development Service Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Viral Vector Development Service Revenue Market Share in 2019
Figure 21. Global Top 10 Players Viral Vector Development Service Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Viral Vector Development Service Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Viral Vector Development Service Revenue Market Share by Regions (2015-2020)
Figure 25. Global Viral Vector Development Service Revenue Market Share by Regions in 2018
Figure 26. North America Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 27. Europe Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 29. South America Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 31. North America Viral Vector Development Service Revenue Market Share by Countries (2015-2020)
Figure 32. North America Viral Vector Development Service Revenue Market Share by Countries in 2019
Figure 33. USA Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 34. Canada Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 36. Europe Viral Vector Development Service Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Viral Vector Development Service Revenue Market Share by Countries in 2019
Figure 38. Germany Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 39. UK Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 40. France Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 41. Russia Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 42. Italy Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Viral Vector Development Service Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Viral Vector Development Service Revenue Market Share by Countries in 2019
Figure 45. China Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 46. Japan Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 47. Korea Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 48. India Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 50. South America Viral Vector Development Service Revenue Market Share by Countries (2015-2020)
Figure 51. South America Viral Vector Development Service Revenue Market Share by Countries in 2019
Figure 52. Brazil Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Viral Vector Development Service Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Viral Vector Development Service Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 57. UAE Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Viral Vector Development Service Revenue and Growth Rate (2015-2020)
Figure 60. Global Viral Vector Development Service Revenue Share by Type (2015-2020)
Figure 61. Global Viral Vector Development Service Revenue Share by Type in 2019
Figure 62. Global Viral Vector Development Service Market Share Forecast by Type (2021-2025)
Figure 63. Global Retroviral Vectors Revenue Growth Rate (2015-2020)
Figure 64. Global Lentiviral Vectors Revenue Growth Rate (2015-2020)
Figure 65. Global Adenoviral Vectors Revenue Growth Rate (2015-2020)
Figure 66. Global Adeno-associated Viral Vectors Revenue Growth Rate (2015-2020)
Figure 67. Global Others Viral Vectors Revenue Growth Rate (2015-2020)
Figure 68. Global Viral Vector Development Service Revenue Share by Application (2015-2020)
Figure 69. Global Viral Vector Development Service Revenue Share by Application in 2019
Figure 70. Global Viral Vector Development Service Market Share Forecast by Application (2021-2025)
Figure 71. Global Pharmaceutical Manufacturers Revenue Growth Rate (2015-2020)
Figure 72. Global Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 73. Global Research Institutes Revenue Growth Rate (2015-2020)
Figure 74. Global Viral Vector Development Service Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Viral Vector Development Service Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Viral Vector Development Service Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Viral Vector Development Service Revenue Market Forecast (2021-2025)
Figure 78. Europe Viral Vector Development Service Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Viral Vector Development Service Revenue Market Forecast (2021-2025)
Figure 80. South America Viral Vector Development Service Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Viral Vector Development Service Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
UJIFILM Diosynth Biotechnologies
Cell and Gene Therapy Catapult
UniQure
Sanofi
Brammer Bio
Spark Therapeutics
FinVector
MassBiologics
Cobra Biologics
Reason to Buy
- Current and future of Service & Software Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Service & Software Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Service & Software Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Service & Software Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets